Michael White, BS, CNMT | Hartford Cardiology

Michael White, BS, CNMT
Email:

Specialty:

Nuclear Cardiology, administration

Philosophy:

I believe the most important thing that we can do in medicine is to care about our patients. Not just care for them but care about them. Working in this field has helped me to develop a proper perspective on life; its fragility and genuine empathy for our patients. In my current role at Hartford Cardiology, I hope to assemble like-minded staff, create a caring and compassionate environment and make coming to see our medical providers as pleasant an experience as possible.

Profile:

I started my career in nuclear medicine 23 years ago working at Yale-New Haven Hospital and Yale University where I was involved in both clinical nuclear medicine and medical research. From there I went on to help open the new Nuclear Cardiology Laboratory at Hartford Hospital where I served as department manager and helped to develop the nuclear cardiology animal research lab. I continued my career in the Hartford area as a co-owner of Connecticut Cardiovascular Services which began as a mobile imaging service and grew to provide nuclear cardiology services at fixed sites as well. It was here that Dr. Knox and I first met and began working together. My knowledge of starting a nuclear lab took me next to Westerly, RI where I opened a new lab for Cardiology Specialists, Ltd. where I worked as the chief technologist for the next seven years. It was from there that I reunited with Dr. Knox to join Hartford Cardiology Group as the practice manager.

Curriculum Vitae

Education:

2001-2004 Christian International School of Theology, Santa Rosa Beach, FL
B.Th. Biblical Studies

1993-1996 Quinnipiac College, Hamden, CT
B.S. Health/Science Studies

1989-1991 South Central Community College, New Haven, CT
A.S. Nuclear Medicine Technology

Professional Affiliations:

American Society of Nuclear Cardiology
Society of Nuclear Medicine, Technologist Section
Society of Nuclear Medicine, New England Chapter
Nuclear Medicine Technology Certification Board

Experience:

2012 to Date Hartford Cardiology Group, West Hartford, Connecticut
Practice Manager

2005 to 2012 Cardiology Specialists Limited, Westerly, Rhode Island
Chief Technologist

2000 to Date Astellas Pharma US, Deerfield, Illinois
Nuclear Cardiology Technical Consultant

2000 to 2005 Connecticut Cardiovascular Services, LLC, Hartford, Connecticut
Co-Owner, Technical Director

1996 to 2000 Hartford Hospital, Hartford, Connecticut
Manager, Nuclear Cardiology

1996 to 2000 ADAC Laboratories, Milpitas, California
Technical Consultant

1994 to 2000 Springfield Community Technical College, Springfield, Massachusetts
Clinical Instructor, Cardiology

1994 to 1996 Hartford Hospital, Hartford, Connecticut
Staff Technologist, Nuclear Cardiology

1994 Lawrence and Memorial Hospital, New London, Connecticut
Staff Technologist, Nuclear Medicine

1991 to 1994 Yale-New Haven Hospital, New Haven, Connecticut
Staff Technologist/Research,Technologist Nuclear Cardiology

1991 to 1994 Gateway Community Technical College, New Haven, Connecticut
Clinical Instructor, Cardiology

1990 to 1991 Milford Hospital, Milford, Connecticut
Staff Technologist, Nuclear Medicine

1989 to 1991 Yale University, New Haven Connecticut
Research Technologist

PUBLICATIONS

Manuscripts:

Optimizing Myocardial SPECT Perfusion Imaging: An Introduction to Attenuation Correction. Michael P. White, Dawn M. Cross. New England Journal of Nuclear Medicine Technology. Fall 1996, 20:1,4.
Clinical Comparison of Circular vs. Non-circular Orbit Using Tc-99m Myocardial SPECT Imaging.
Michael P. White, April Russell, Victor A. Mascitelli, Robert S. Morris, Adel R. Shehata, Gary V. Heller. Journal of Nuclear Medicine Technology, 1996, 25:37-40.
Impact of Acute Propanolol Administration on Dobutamine-Induced Mycardial Ischemia as Evaluated by Myocardial Perfusion Imaging and Echocardiography. Adel R Shehata, Linda D Gillam, Steven D Herman, Victor M Mascitelli, Alan W Ahlberg, Michael P White, C Chen, David D Waters, Gary V Heller. American Journal of Cardiology 1997; 80:268-272.
Dipyridamole-Dobutamine Stress with Tc-99m Sestamibi Tomographic Myocardial Perfusion Imaging. Adel R. Shehata, Alan W. Ahlberg, Michael P. White, April Russell, Irene A. Fleming, Michael G. Levine, Jeffrey F. Mather, David Waters, Gary V. Heller. American Journal of Cardiology 1998; 82:520-523.
The Role of the Technologist in Nuclear Cardiology. Michael P. White, April Mann. Journal of Nuclear Cardiology 1998; 5:438-441.
Impact of Arm Positioning Upon Rest/Stress Tc-99m Sestamibi Tomographic Imaging. Dawn M. Cross, Michael P. White, April Russell, Carol C. McGill, Denise A. Clapp, Joseph M. Phillips, Melissa Ferraro-Borgida, Gary V. Heller. Journal of Nuclear Cardiology 1999; 6:163-168.
An Evaluation of Technetium-99m Red Blood Cell Labeling Efficiency and Clinical Impact on Pediatric Oncology Patients. Michael P. White, Dawn M. Cross, April Russell, Gary V. Heller. Journal of Nuclear Medicine Technology, 1998; 26:265-268.
Effect of Time on Liver Clearance of 99mTc-Tetrofosmin Following Acute Chest Pain Injection: When Should Imaging Begin? April Russell, Alan Ahlberg, Michael White, Dawn M. Cross, Jose Piriz, Scott Morris, Gary V. Heller. Journal of Nuclear Medicine Technology, 1998; 26:186-190.
Gated SPECT Imaging 101. Michael P. White, April Mann, Mark A. Saari. Journal of Nuclear Cardiology 1998; 5:523-526.
Acute Myocardial Perfusion Imaging for the Technologist. April Mann, Michael White. Journal of Nuclear Cardiology 1998; 5:622-625.
Fasting Myocardial and Non-Fasting Iodine-123-Idophenylpentadecanoic Acid SPECT Imaging in Coronary Artery Disease. Gary V. Heller, Ami Iskandrian, Cesare Orlandi, Alan Ahlberg, Jackyeong Heo, April Russell, Michael White, Andre Gagnon, Raymond Taillefer. Journal of Nuclear Medicine 1998; 39:2019-2022.
Functional Assessment with Electrocardiographic Gated Single-Photon Emission Computed Tomogrphy Improves the Ability of Technetium-99m Sestamibi Myocardial Perfusion Imaging to Predict Myocardial Viability in Patients Undergoing Revascularization. Michael G. Levine, Carol C. McGill, Alan W Ahlberg, Michael P. White, Satyendera Giri, Baber Shareef, David Waters, Gary V. Heller. American Journal of Cardiology 1999; 83:1-5.
Comparison of Exercise, Dipyridamole, Adenosine and Dobutamine Stress Using Technetium-99m Tetrofosmin Tomographic Imaging. Michael G. Levine, Alan W. Ahlberg, April Mann, Michael P. White, Carol C. McGill, Carlos Mendes de Leon, Jose M. Piriz, David Waters, Gary V. Heller. Journal of Nuclear Cardiology 1999; 6:389-396.
Comparison of Acute Rest Myocardial Perfusion Imaging and Serum Markers of Myocardial Injury in Patients with Chest Pain Syndroms. Maria Duca, Scott Morris, Alan Wu, Giselle Cyr, Alan Ahlberg, Michael White, April Mann, Satyendra Giri, David Waters, Gary Heller. Journal of Nuclear Cardiology 1999; 6: 570-576.
Impact of Limited Treadmill Exercise on Adenosine Tc-99m Sestamibi Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging in Coronoary Artery Disease. Gohar Jamil, Alan Ahlberg, Michael Elliott, Robert Hendel, Thomas Holly, Carol McGill, Marlene Sarkis, Michael White, Jeffery Mather, David Waters, Gary Heller. American Journal of Cardiology 1999; 84:400-403.
Pharmacologic Stress Testing: Understanding the Options. Michael P. White. Journal of Nuclear Cardiology 1999; 6:672-675.
Comparison of Electrocardiographic-Gated Technetium-99m Sestamibi Single-Photon Emission
Computed Tomographic Imaging and Rest-Redistribution Thallium-201 in the Prediction of Myocardial Viability. Brett H. Duncan, Alan W. Ahlberg, Michael G. Levine, Carol C. McGill, April Mann, Michael P. White, Jeffrey F. Mather, David D. Waters, Gary V. Heller. Am J Cardiol, 2000; 85: 680-684.
Identification of Coronary Thrombus with a IIb/IIIa Platelet Inhibitor Radiopharmaceutical, Tc-99m DMP-444: A Canine Model. Joseph Mitchel, David Waters, Tianjie Lai, Michael White, Todd Alberghini, Ahmad Salloum, David Knibbs, Dadong Li, Gary Heller. Circulation 2000; 101:1643-46.
Education: It’s Your Responsibility. Michael White, Wendy Bruni. ASNC Newsletter May 2000.
Your Ship Won’t Float if It’s Full of Holes. Michael White, Wendy Bruni. ASNC Newsletter July 2000.
Are We the Best We Can Be? Michael White, Wendy Bruni. ASNC Newsletter September 2000.
You’re a Nuclear Medicine Technologist, But Is That All You Do? Michael White. ASNC Newsletter February 2001.
Survivor 3: The Technologist Shortage, Part I. Michael White. ASNC Newsletter April 2001.
Survivor 3: The Technologist Shortage, Part II. Michael White. ASNC Newsletter June 2001.
Survivor 3: The Technologist Shortage, Part III. Michael White. ASNC Newsletter August 2001.
Basic Life Support: Is Basic Enough Anymore? Michael White. ASNC Newsletter October 2001.
CEUs: They’re Not Just For Meetings Any More. Michael White, Wendy Bruni. ASNC Newsletter October 2002.

Abstracts:

Continuous Monitoring of Left Ventricular Ejection Fraction on Patients Undergoing Mental Stress. Michael P. White, Diwaker Jain. New England Chapter, Technologist Section, Society of Nuclear Medicine, June 1991
The Effect of Milk Administration on Hepatic and Cardiac Clearance Following Tc-99m Sestamibi Injection. Michael P. White, Vincent L. Perez, Robert C. Fetterman, Jennifer A. Mattera, Barry L. Zaret, Frans J. Wackers, Albert J. Sinusas. Journal of Nuclear Medicine Technology, June 1992.
Sinusas A, White M, Perez V, Mattera J, Zaret B, Wackers F. Delaying Post-exercise Tc99m-sestamibi Imaging May Result in Underestimation of Ischemia. Circulation 1992; 86: I-505.
Assessment of Risk Area with Tc-99m Sestamibi SPECT: Methodology, Reproducibility and Correlation with Flow. Michael P. White, Q.X. Shi, Wendy L. Bruni, Michael J. Singer, Donald P. Dionne, Robert C. Fetterman, Frans J. Wackers, Barry L. Zaret, Albert J. Sinusas. Journal of Nuclear Medicine, June 1993, 21:103.
Defect Size Can Be Reproducibly Quantified with Planar Sestamibi Imaging in a Closed Chest Canine Infarct Model. Wendy L. Bruni, Q.X. Shi, Michael J. Singer, Michael P. White, Donald P. Dionne, Frans J. Wackers, Barry L. Zaret, Albert J. Sinusas. Journal of Nuclear Medicine, June 1993, 21:103.
Correlation of Planar Sestamibi Defect Size with Flow In a Chronic Infarct Model: End-diastolic Image Analysis Minimizes Geometric Induced Effects. Q.X. Shi, Wendy L. Bruni, Michael J. Singer, Michael P. White, Donald P. Dionne, Robert C. Fetterman, Frans J. Wackers, Barry L. Zaret. Journal of Nuclear Medicine, June 1993, 34:97P.
Clinical Comparison of Circular vs. Non-circular Orbit Using Tc-99m Myocardial SPECT Imaging. Michael P. White, April Russell, Michael V. McMahon, Victor Mascitelli, Gary V. Heller Journal of Nuclear Medicine, June 1995, 36:263P .
Comparison of Left Ventricular Function Using Gated SPECT Perfusion Images and Echocardiography in Patients with Cardiomyopathy. Michael V. McMahon, Michael P. White, April Russell, Mark I. Travin, Linda D. Gillam, Gary V. Heller. Journal of Nuclear Medicine Technology, June 1995, 23:124.
Does Beta Blocker Therapy Affect Dobutamine Stress? Evaluation of Myocardial Perfusion Imaging and Wall Motion. Victor A. Mascitelli, Tawhid A. Shuaib, Alan W. Ahlberg, Rene A. Fleming, Michael P. White, April Russell, Michael V. McMahon, Steven D. Herman, Chunguang Chen, Linda D. Gillam, Gary V. Heller. Circulation, October 1995, 92:I448.
I-123 Iodophenylpentadecanoic Acid (IPPA) Versus Tc-99m Sestamibi Myocardial Perfusion Imaging in Coronary Patients. Jun V. Quion, Jose M. Piriz, Alan W. Ahlberg, Victor A. Mascitelli, Michael P. White, Cesare Orlandi, Raymond Taillefer, David Waters, Gary V. Heller. Journal of Nuclear Medicine, May 1996, 37:37P.
Technetium-99m Labeled Red Blood Cells: A Clinical Evaluation of Labeling Efficiency for Several Manufacturer’s Methods. Michael P. White, Dawn M. Cross, April Russell, Michael V. McMahon, Gary V. Heller. Journal of Nuclear Medicine Technology, June 1996, 24:173-174.
Iridium-191m- A Radiopharmaceutical For The Evaluation Of Ventricular Function: Technical Considerations. Michael P. White, Jose Piriz, Michael V. McMahon, April Russell, Dawn M. Cross, Pamela Day, Alan Packard, Gary V. Heller. Journal of Nuclear Medicine Technology, June 1996, 24:174.
Effect of Time on Liver Clearance of 99mTc-Tetrofosmin Following Acute Chest Pain Injection: When Should Imaging Begin? April Russell, Michael V. McMahon, Angela Depergola, Alan Ahlberg, Michael White, Dawn M. Cross, Jose Piriz, Scott Morris, Gary V. Heller. Journal of Nuclear Medicine Technology, June 1996, 24:155.
Are Gadolinium-153 Attenuation Corrected Myocardial SPECT Images Effected by Tc99m-Sestamibi’s Increased Hepatic Activity. MP White, MV McMahon, A Shehata, J Piriz, GV Heller. Journal of Nuclear Medicine Technology, June 1996, 24:156.
Relatioship Between Early Rest and Predischarge Stress Tc-99m SPECT Imaging in Patients with Spontaneous Chest Pain. Scott Morris, Alan Ahlberg, Adel Shehata, Jose Piriz, Edouard Daher, Michael White, Donna Natale, Steven Herman, Frans Wackers, Gary Heller. Circulation, October 1996, 94:I509.
Impact of Body Habitus on Accuracy of Standardized Attenuation Correction Reconstruction. Michael P. White, Dawn M. Cross, Alan W. Ahlberg, Gary V. Heller. Journal of Nuclear Cardiology, Supplement; January/February 1997, 4: S1.
Myocardial Viability: A Comparison of Tc-99m Sestamibi Gated SPECT Imaging and Rest-Redistribution Thallium. Michael G. Levine, Michael P. White, Barbar Shareef, Alan W. Ahlberg, Carol C. McGill, S Giri, David Waters, Gary V. Heller. Journal of Nuclear Cardiology, Supplement; January/February 1997, 4: S81.
Correlation of Serum Markers and Acute Myocardial Perfusion Imaging. Maria D. Duca, Andrea T. Fossati, Robert S. Morris, AH Wu, Alan W. Ahlberg, Y Feng, Michael P. White, Gary V. Heller. Journal of Nuclear Cardiology, Supplement; January/February 1997, 4: S58.
Correlation of Acute Tc-99m SPECT Imaging and Coronary Artery Disease. Andrea T. Fossati, Robert S. Morris, Alan W. Ahlberg, Giselle M. Cyr, Carol C. McGill, April Russell, Michael P. White, Frans J. Wackers, Gary V. Heller. Journal of Nuclear Cardiology, Supplement; January/February 1997, 4: S75.
Gender Differences in Acute Chest Pain Myocardial Imaging. Michael G. Levine, Frans J. Wackers, Robert S. Morris, Carol C. McGill, April Russell, Michael P. White, David Waters, Gary V. Heller. Journal of Nuclear Cardiology, Supplement; January/February 1997, 4: S69.
Impact of Stress Protocols Upon Myocardial Uptake with Tc-99m Tetrofosmin. Michael G. Levine, Alan W. Ahlberg, Michael P. White, Andrea T. Fossati, Carol C. McGill, Giselle M. Cyr, April Russell, Jose M. Piriz, Gary V. Heller. Journal of Nuclear Medicine, May 1997, 38:73P.Evaluation of New ADAC Vertex Collimator for Tc-99m SPECT Myocardial Perfusion Imaging. April Russell, Michael P. White, Dawn M. Cross, Andrea T. Fossati, Michael G. Levine, Carol C. McGill, Gary V. Heller. Journal of Nuclear Medicine Technology, June 1997, 25:151-152.
Effectiveness of In-vitro Labeling for Pre-chemotherapy Assessment of Ventricular Function in Pediatric Oncology Patients. Michael P. White, April Russell, Dawn M. Cross, Denise A. Clapp, Irene R. Gillan, Gary V. Heller. Journal of Nuclear Medicine Technology, June 1997, 25:151.
Does Body Habitus Impact Standardized Attenuation Correction Reconstruction: A Correlation with Cardiac Catheterization. Michael P. White, April Russell, Dawn M. Cross, Alan W. Ahlberg, Michael G. Levine, Andrea T. Fossati, Gary V. Heller. Journal of Nuclear Medicine Technology, June 1997, 25:136.
Myocardial Viability: A Prospective Comparison of Technetium-99m Sestamibi Gated SPECT Versus Rest-Redistribution Thallium-201 Myocardial Perfusion Imaging. Michael G. Levine, Carol C. McGill, Michael P. White, Alan W. Ahlberg, Peter G. Danias, Andrea T. Fossati, Satendra Giri, David Waters, Gary V. Heller. Circulation, October 1997, 96:I-443.
Impact of Arm Position Upon Defect Score with Tc-99m Sestamibi SPECT Perfusion Imaging. Dawn M. Cross, April Russell, Michael P. White, Carol C. McGill, Denise A. Clapp, Gary V. Heller. New York /New England Chapter, Fall Symposium, Society of Nuclear Medicine, October 1997
Visualized Wall Motion Assessment Correlates With Quantitative Ejection Fraction Using Tc-99m Sestamibi ECG Gated SPECT Imaging in Patients With Dilated Cardiomyopathy. Gohar Jamil, Alan W. Ahlberg, Peter G. Danias, Carol C. McGill, April Russell, Michael P. White, David Waters, Gary V. Heller. JACC, Supplement, February 1998, 31:440A.
Low-Dose Dobutamine ECG Gated SPECT Myocardial Perfusion Imaging with Technetium-99m Sestamibi Predicts Myocardial Viability: A Prospective Study. Michael G. Levine, Carol C. McGill, Rabih R. Azar, Dawn M. Cross, Michael P. White, Alan W. Ahlberg, David Waters, Gary V. Heller. JACC, Supplement, February 1998, 31:44A.
Comparison of Iridium-191m and Tantalum-178 for First-pass Assessment of Left Ventricular Fuction Using the Multiwire Camera. Michael P. White, Jeff L. Lacy, Carol C. McGill, Nisha Nayak, Pamela J. Day, Alan B. Packard, Gary V. Heller. Journal of Nuclear Medicine Technology, June 1998; 26:121.
Arm Positioning Does Not Affect the Number, Size or Severity of Myocardial Perfusion Defects with Tc-99m Sestamibi SPECT Imaging. Dawn M. Cross, Michael P. White, April Russell, Carol C. McGill, Denise A. Clapp, Joseph M. Phillips, Melissa J. Ferraro-Borgida, Gary V. Heller. Journal of Nuclear Medicine Technology, June 1998; 26:115.
Does the Tpye of Stress Affect Tc-99m Tetrofosmin Myocardial Count Statistics? April Russell, Joseph M. Phillips, Alan W. Ahlberg, Michael P. White, Niall Moyna, Michael G. Levine, Gary V. Heller. Journal of Nuclear Medicine Technology, June 1998; 26:116.
Assessment of Left Ventricular Function and Perfusion During Pharmacologic Stress Using the Multiwire Camera and Tantalum-178. M. Reza Mansoor, Michael P. White, Carol C. McGill, Jeff L. Lacy, Gohar Jamil, Melissa J. Ferraro-Borgida, Giselle M. Cyr, Alan W. Ahlberg, Gary V. Heller. Journal of Nuclear Medicine, Supplement, May 1998; 39:76P.
ECG-Gated Low Dose Dobutamine Tc-99m Sestamibi SPECT Myocadial Perfusion Imaging Accurately Predicts Myocardial Viability: Comparison with Rest-Redistribution thallium-201. Brett H. Duncan, Michael G. Levine, Carol C. McGill, Michael P. White, Alan W. Ahlberg, Jeffery F. Mather, David Waters, Gary V. Heller. JACC, Supplement, February 1999; 33:468A.
Impact of Glucagon Administration on Dobutamine Stress Testing Using Tc-99m Sestamibi Single PhotonComputed Emission Tomography (SPECT) Imaging in Patients Receiving Acute Beta Adrenergic Receptor Blockade. Dakshina R. Murthy, Deborak Katten, Alan W. Ahlberg, Michael P. White, C. Michael White, David D. Waters, Gary V. Heller. JACC, Supplement, February 1999; 33:417A.
Defect Extent and Severity are Underestimated with Dobutamine Stress Using Technetium-99m Tetrofosmin Single-Photon Computed Emission Tomographic Myocardial Perfusion Imaging. M. Reza Mansoor, Alan W. Ahlberg, Niall M. Moyna, Michael G. Levine, Carol C. McGill, April Mann, Michael P. White, David Waters, Gary V. Heller. JACC, Supplement, February 1999; 33:418A
Stress Technetium-99m Sestamibi Gated SPECT Can Differentiate Non-ischemic, Ischemic or Combined Origins of Left Ventricular Dysfunction. Gohar Jamil, Alan W. Ahlberg, Michael P. White, Brett H. Duncan, Dakshina R. Murthy, Jeffery F. Mather, Francis J. Kiernan, Peter G. Danias, David D. Waters, Gary V. Heller. Journal of Nuclear Medicine, Supplement, May 1999;
Limited Treadmill Exercise Combined with a Shortened Adenosine Infusion Does Not Increase Myocardail Perfusion Defect Size Using Tc-99m Sestamibi SPECT Imaging in Patients with Coronary Artery Disease. Gohar Jamil, Alan W. Ahlberg, Marlene Sarkis, Carol C. McGill, Michael P. White, Michael D. Elliott, Thomas A. Holly, Carol Cook, Gary V. Heller, Robert C. Hendel. Journal of Nuclear Medicine, Supplement, May 1999;
Utility of Tc-99m Sestamibi Gated Single Emission Computed Tomographic (SPECT) Imaging to Assess Left Ventricular Remodeling Following Primary Angioplasty. DK Murthy, D Katten, CC McGill, AC Olatidoye, N Moyna, MP White, DD Waters, GV Heller. Journal of Nuclear Medicine, Supplement, May 1999; 40:153P.
Evaluation of Iterative Reconstruction versus Filtered Back-Projection for SPECT Myocardial Perfusion Imaging with Tc-99m Sestamibi. Michael P. White, Mohammed R. Mansoor, Mary DeGroot, Alan W. Ahlberg, Gary V. Heller. Journal of Nuclear Medicine Technology, May 1999; 27:160.
Identification of Coronary Thrombus with a IIb/IIIa Platelet Inhibitor Pharmaceutical, Tc99m-DMP-444: A Canine Model. Gary V. Heller, David D. Waters, Tianjie Lai, Michael P. White, Ahmad Salloum, Tod Albergini, David Knibbs, Joseph Mitchel. Circulation, November 1999, 100:I-518.
Regional Left Ventricular Response to Low-dose Dobutamine Infusion During ECG-gated Tc-99m Sestamibi SPECT Image Acquisition Accurately Predicts Global Left Ventricular Function After Revascularization in Patients with Coronary Artery Disease and Left Ventricular Dysfunction. Brett Duncan, Alan Ahlberg, Domenic Marini, Carol McGill, Michael White, Jeffrey Mather, David Waters, Gary Heller, JACC, Supplement, February 2000;
Angiographic No-reflow During Primary Angioplasty Portends Impaired Six-week Perfusion and Functional Recovery: A Dipyridamole Tc-99m Sestamibi Gated SPECT Imaging Study. Satyendra Giri, Joseph Mitchel, Abdul Alkeylani, Daborah Katon, Daniel Fram, Jeffrey Hirst, Michael White, Jeffrey Popma, Francis Kiernan, Gary Heller. JACC, Supplement, February 2000;
Detection of Platelet-rich Coronary Thrombi Using a Novel Radionuclide Imaging Agent (Tc-99m DMP-444) in a Canine Model: Interaction with Abciximab. Joseph Mitchel, Tianje Lai, Michael White, Dadong Li, Tod Alberghini, Ahmad Salloum, David Knibbs, Satyendra Giri, David Waters, Gary Heller. JACC, Supplement, February 2000;
The Addition of Low-level Treadmill Exercise Reduces the Time Between Injection and Imaging for Patients Undergoing Adenosine Rest/Stress SPECT Myocardial Perfusion Imaging with Tc-99m Sestamibi. Michael White, Denise Emerson, Robert Smith, Thomas Knox. Journal of Nuclear Medicine, Supplement, May 2005; 46:497P.

Invited Presentations:

February 1993 Dobutamine and Sestamibi Imaging. New England Chapter, Society of Nuclear Medicine Winter Meeting, North Conway, NH.
August 1993 Planar Myocardial Perfusion Imaging: Techniques, Artifacts and Errors. Nuclear Cardiology Grass Roots Seminar. Yale-New Haven Hospital, New Haven, CT.
April 1997 Technologist’ Workshop: Gated SPECT Imaging. International Conference of Nuclear Cardiology. Florence, Italy.
June 1997 Acute Chest Pain Imaging. Technologist Continuing Education, 44th Annual Society of Nuclear Medicine Scientific Session. San Antonio, TX.
September 1997 Technical Considerations in Image Acquisition. 2nd ASNC Tutorial in Nuclear Cardiology. Boston, MA.
January 1998 Acute Chest Pain Imaging and the Technologist. Northeast Nuclear Cardiology Working Group Symposium. New York, NY
June 1998 Attenuation and Scatter Correction. Technologist Continuing Education, 45th Annual
Society of Nuclear Medicine Scientific Session. Toronto, Ontario, Canada
April 2000 Pharmacologic Stress Testing: The Keys to Understanding Your Options. 4th Annual Southern Connecticut Spring Meeting, Society of Nuclear Medicine, New England Chapter. North Haven, CT
June 2000 What Does the Next Millennium Mean for Nuclear Cardiology. 47th Annual Society of Nuclear Medicine Scientific Session. St. Louis, MO
January 2003 Pharmacologic Stress Testing: The Keys to Understanding Your Options. Cardiology Grand Rounds Our Lady of Fatima/St. Joseph’s Hospital, North Providence, RI
March 2003 Patient Assessment. Cardiology Dinner Program. Princeton Medical Center, Princeton, NJ
April 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Cardiology Dinner Program. Lebanon, PA
April 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Cardiology Dinner Program. Geisinger Health Systems, Wilkes-Barre, PA
April 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Cardiology Lunch Program. Roosevelt-St. Luke’s Hospital, New York, NY
May 2003 The Role of Adenosine and Exercise In Improving Lab Efficiency. Cardiology Dinner Program. San Antonio, TX
May 2003 The Role of Adenosine and Exercise In Improving Lab Efficiency. Cardiology Dinner Program. Austin Cardiology Associates, Austin, TX
May 2003 Patient Assessment. Cardiology Dinner Program. Memorial-Sloan Kettering Hospital, New York, NY
May 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Cardiology Dinner Program. Primary Care and Cardiology Associates, White Plains, NY
June 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Cardiology Dinner Program. Geisinger Health Systems, Danville, PA
August 2003 Technical Considerations in Myocardial Perfusion Imaging. Cardiology Dinner Program. Virginia Cardiovascular Specialists, Richmond, VA
September 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Cardiology Dinner Program. Cardiology Associates of Southeastern PA, Philadelphia, PA
September 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Cardiology Dinner Program. Pittsburgh, PA
September 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Cardiology Dinner Program. Philadelphia, PA
September 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Mid-Atlantic Region, Society of Nuclear Medicine, Fall Imaging Symposium, Ocean City, MD
September 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Mid-West Region, Society of Nuclear Medicine, Fall Meeting, Wichita, KS
October 2003 Technical Considerations in Myocardial Perfusion Imaging: Houston, We Have a Problem. Cooper Health Systems, CE Symposium, Cherry Hill, NJ
October 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Princeton Medical Center. Dinner Program, Princeton, NJ
October 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. Philadelphia, PA
November 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Program, John Hopkins Medical Center, Baltimore, MD
November 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Program, Medical College of Virginia, Richmond, VA
November 2003 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Program, Allegany Valley Hospital, Pittsburgh, PA
January 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. Dinner Program, Allentown, PA
January 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Lunch Program, Lourdes Hospital, Binghamton, NY
February 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Dinner Program, Southeastern Heart and Vascular Center, Greensboro, NC
February 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Lunch Program, Wilson Hospital, Binghamton, NY
March 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Lunch Program, Little Rock, AR
April 2004 Role of Pharmacologic Stress In Improving Lab Efficiency. and Technical Considerations in Myocardial Perfusion Imaging. Spring Nuclear Cardiology Symposium, Geneva on the Lake, Geneva, NY.
April 2004 Patient Assessment. CE Program. Geisinger Health System. Danville, PA
April 2004 Technical Considerations in Myocardial Perfusion Imaging. CE Dinner Program. Voorhees, NJ
May 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Lunch Program, Pine Bluff, AR
June 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. Nuclear Cardiology Symposium, Buffalo, NY
August 2004 Technical Considerations in Myocardial Perfusion Imaging and The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Dinner Program. Roanoke, VA
August 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. Twin Tier Cardiovascular Associates Lunch, Elmira, NY
August 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Dinner Program, San Antonio, TX
September 2004 Technical Considerations in Myocardial Perfusion Imaging. CE Dinner Program. Rochester, NY
September 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Dinner Program, Brick, NJ
September 2004 Technical Considerations in Myocardial Perfusion Imaging. CE Dinner Program. Buffalo, NY
October 2004 Technical Considerations in Myocardial Perfusion Imaging. CE Dinner Program. Rochester, NY
October 2004 Technical Considerations in Myocardial Perfusion Imaging. CE Dinner Program.
Rocky Hill, CT
October 2004 Technical Considerations in Myocardial Perfusion Imaging. CE Dinner Program. Albany, NY
October 2004 Patient Assessment. CE Dinner Program, Little Rock, AR
October 2004 Technical Considerations in Myocardial Perfusion Imaging. CE Dinner Program. Hagerstown, MD
November 2004 Risk Stratification of Patients with Ischemic Heart Disease: The Use of Myocardial Perfusion Imaging. CE Dinner Program. Baltimore, MD
November 2004 Risk Stratification of Patients with Ischemic Heart Disease: The Use of Myocardial Perfusion Imaging. CE Dinner Program. Harrisburg, PA
November 2004 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Lunch Program, Middletown, NY
January 2005 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Dinner Program, Allentown, PA
February 2005 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Lunch Program, Norfolk, VA
February 2005 Technical Considerations in Myocardial Perfusion Imaging. CE Dinner Program. Baltimore, MD
February 2005 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Lunch Program, St. Vincent’s Medical Center, New York, NY
February 2005 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Dinner Program, Portsmouth, VA
April 2005 The Role of Pharmacologic Stress In Improving Lab Efficiency. Spring Meeting, Tennessee Society of Nuclear Medicine Technology, Knoxville, TN
May 2005 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Dinner Program, Providence, RI
June 2005 The Role of Pharmacologic Stress In Improving Lab Efficiency. CE Dinner Program, Atlanta, GA
August 2011 Launching a New Practice Group in Today’s Changing Environment. Astellas Pharma US National Technical Consultant Group Meeting. Chicago, IL
February 2012 Lexiscan (Regadenoson) Injection the First and Only Selective A2A Adenosine Receptor Agonist, East Greenwich, RI
March 2012 Lexiscan (Regadenoson) Injection the First and Only Selective A2A Adenosine Receptor Agonist, Hartford, CT